DALIRESP for Chronic obstructive pulmonary disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where DALIRESP was used for Chronic obstructive pulmonary disease.
Most Reported Side Effects for DALIRESP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 27 | 31.4% | 0 | 3 |
| Insomnia | 14 | 16.3% | 0 | 2 |
| Nausea | 14 | 16.3% | 0 | 2 |
| Weight decreased | 12 | 14.0% | 1 | 3 |
| Dizziness | 9 | 10.5% | 0 | 1 |
| Anxiety | 7 | 8.1% | 0 | 0 |
| Depression | 7 | 8.1% | 0 | 2 |
| Drug ineffective | 5 | 5.8% | 0 | 1 |
| Headache | 5 | 5.8% | 0 | 1 |
| Suicidal ideation | 5 | 5.8% | 0 | 0 |
| Tremor | 5 | 5.8% | 0 | 2 |
Other Drugs Used for Chronic obstructive pulmonary disease
TIOTROPIUM (20,175)
FLUTICASONE\SALMETEROL (8,896)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (8,730)
ALBUTEROL (8,572)
BUDESONIDE\FORMOTEROL (6,539)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (4,580)
UMECLIDINIUM\VILANTEROL TRIFENATATE (4,512)
DUPILUMAB (3,526)
ALBUTEROL\IPRATROPIUM (3,289)
ACLIDINIUM (2,321)